Skip to main content

Clinical drug monitoring resources

Clinical drug monitoring resources

We’ve developed a vast number of reference materials—everything from comprehensive reporting and drug monitoring testing guides, to Health Trends® reports that provide insights into the drug misuse epidemic in the US—that can help empower better patient care and help you make more informed decisions in the fight against drug misuse.

New medMATCH® Report Resources

Our enhanced medMATCH® report provides actionable insights and “at-a-glance” interpretation. Below you’ll find resources highlighting the features of the report, information about our test panels and recent test code changes, and an explanation of our simplified ordering process.

The following resources are provided to assist patients in completing at-home or self-collection of lab samples for physician-ordered drug monitoring tests. The resources include an instruction guide and demonstration video for oral fluid self-collection, and an instruction guide for urine specimen self-collection.

Video: A demonstration of Oral Fluid Sample Collections with Oral-Eze®

The COVID-19 pandemic presents some difficult challenges to providing appropriate levels of drug monitoring for opioids and other prescription drugs. Below are some resources we hope will be helpful.

Video: Telemedicine: Prescribing during the COVID-19 pandemic

Video: Medications Adherence: Challenges during the COVID-19 pandemic

Video: Increased Drug Misuse during the COVID-19 pandemic

Drug Misuse in America 2021: Physician Perspectives and Diagnostic Insights on the Drug Crisis and COVID-19, a Quest Diagnostics Health Trends report, explores the impact of the pandemic on drug misuse using nearly 5 million deidentified laboratory tests performed by Quest Diagnostics from 2011 through 2020 for patients in all 50 states and the District of Columbia.

The report is believed to be the first of its kind that juxtaposes laboratory test results with findings from an online survey of 505 US primary care physicians about the use of controlled prescription medications and illicit drugs in the United States during the COVID-19 pandemic.

To better understand the relationship between the COVID-19 pandemic and the drug misuse epidemic in the US, Quest Diagnostics study investigators analyzed changes in drug positivity rates and drug testing volumes, utilizing deidentified urine drug testing (UDT) results from January 1, 2019 to May 16, 2020.

Study results show that prescription drug monitoring declined during the weeks of the COVID-19 pandemic studied, while positivity for nonprescribed illicit drugs and dangerous drug combinations increased.

Drug Misuse in America 2019: Physician Perspectives and Diagnostic Insights on the Evolving Drug Crisis, a Quest Diagnostics Health Trends™ report, presents findings from analysis of more than 4.4 million de-identified aggregated clinical drug monitoring tests performed by Quest Diagnostics for patients from all 50 states and District of Columbia from 2011 through 2018.

A collaboration between the Center on Addiction and Quest Diagnostics, this report may be the first of its kind, juxtaposing an analysis of more than 4.4 million de-identified clinical drug monitoring tests by Quest Diagnostics and a survey conducted by The Harris Poll of 500 primary care physicians about their patients’ use of controlled substances.

As an industry leader in drug testing, Quest Diagnostics provides a wealth of information and resources to help you make more informed decisions for your patients.

Video – Why Every Clinician Needs to Integrate Drug Monitoring into their Practice with Jeff Gudin, MD

Video - How to Set the Stage for a Drug Monitoring Program with your Patient with Jeff Gudin, MD

Video - How to Share Drug Monitoring Results with Your Patient with Jeff Gudin, MD

Download these helpful resources to navigate our broad menu of tests, including prescription drug medications, other controlled medications, and illicit drugs.

Reference Guide

A complete reference guide by drug class, including our full test menu

Reference Guide

Test List and Panels

Our full test menu, including test codes and panels available

Test List and Panels

Our industry-leading toxicology experts are available to help you with results interpretation. 

Contact us

Call a Quest Diagnostics toxicology consultant specialist today:

1.877.40.RXTOX (1.877.407.9869)

For patients with questions about the testing process or locations, call

1.866.MY.QUEST (1.866.697.8378)